1. Have you changed your DLR personnel monitoring period (i.e. quarterly to 6 months, 6 months to annual)? We went from quarterly to every 6 months on 1/1/2010. 2. Did you experience a change in the number of individuals with dose less than 10 mrem and /or greater than 10 mrem? Greater. 3. What DLR's are used at your site for personnel monitoring (i.e. TLD, OSL)? Who is the processor (i.e. Harshaw, Landauer)? TLDs. We process our own. 4. What is the lowest mrem you report annually? Basis? 10 mrem. LLD determination. 5. What is your criterion for monitoring workers? (i.e. Are workers who never enter the RCA issued a DLR?). Yes, based on area TLD data.
From: Parlatore, Linda M:(GenCo-Nuc) [mailto:[email protected]] Sent: Monday, February 27, 2017 10:58 AM To: [email protected] Cc: Ridge, Rose Marie A:(GenCo-Nuc) Subject: [powernet] Benchmark Response Request Question #1 of 2 *** Exercise caution. This is an EXTERNAL email. DO NOT open attachments or click links from unknown senders or unexpected email. *** TMI is performing a benchmark on external dosimetry. Question #1 (of 2)concerns DLR's (Dosimeter Legal Record - i.e. TLD, OSL). Responses are appreciated. If you would prefer to call instead, I can be reached at 717-948-8075. 1. Have you changed your DLR personnel monitoring period (i.e. quarterly to 6 months, 6 months to annual)? 2. Did you experience a change in the number of individuals with dose less than 10 mrem and /or greater than 10 mrem? 3. What DLR's are used at your site for personnel monitoring (i.e. TLD, OSL)? Who is the processor (i.e. Harshaw, Landauer)? 4. What is the lowest mrem you report annually? Basis? 5. What is your criterion for monitoring workers? (i.e. Are workers who never enter the RCA issued a DLR?) Linda M Parlatore CHP NRRPT Three Mile Island 2625 River Road Middletown, PA 17057 717.948.8075 717.948.8502 (fax) This Email message and any attachment may contain information that is proprietary, legally privileged, confidential and/or subject to copyright belonging to Exelon Corporation or its affiliates ("Exelon"). This Email is intended solely for the use of the person(s) to which it is addressed. If you are not an intended recipient, or the employee or agent responsible for delivery of this Email to the intended recipient(s), you are hereby notified that any dissemination, distribution or copying of this Email is strictly prohibited. If you have received this message in error, please immediately notify the sender and permanently delete this Email and any copies. Exelon policies expressly prohibit employees from making defamatory or offensive statements and infringing any copyright or any other legal right by Email communication. Exelon will not accept any liability in respect of such communications. -EXCIP
